FDA Advisors Leave Door Open To Mix and Match COVID-19 Vaccine Boosters

 
• By Sarah Karlin-Smith
  
white open door red walls
Some VRBPAC members felt a small NIH study was enough to permit an EUA for heterologous boosting. • Source: Alamy

More from Vaccines

More from Pink Sheet